CNS Pharmaceuticals, Inc. (CNSP) vs GT Biopharma, Inc. (GTBP)
A side-by-side comparison of CNS Pharmaceuticals, Inc. and GT Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSP
CNS Pharmaceuticals, Inc.
$4.99HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
GTBP
GT Biopharma, Inc.
$6.23HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — CNSP vs GTBP
growth of $100 · dividends reinvested · last 7yCNSP -100.0% (-85.6%/yr)GTBP -99.7% (-56.4%/yr)GTBP compounded faster over this window
Log scale — wide-divergence pair
CNSP GTBP
CNSP vs GTBP: by the numbers
- •GTBP is the larger company ($8M vs $7M market cap).
Metrics side by side
Valuation
| Metric | CNSP | GTBP |
|---|---|---|
| P/B ratio | 0.40 | 2.20 |
Profitability
| Metric | CNSP | GTBP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -91.75% | -618.74% |
| ROIC | -92.94% | -457.75% |
Growth (annualized)
| Metric | CNSP | GTBP |
|---|---|---|
| Total return CAGR (5Y) | -91.63% | -73.13% |
Frequently asked
- How have CNSP and GTBP total returns compared?
- Over the past 5 years, CNSP delivered -91.63% and GTBP delivered -73.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.